Other names: rhombotin 1, RBTN1, RHOM1, TTG1 HGNC (Hugo): LMO1 Location: 11p15.4 Local order: Telomeric to STK33 gene; centromeric to RIC3 gene.
Protein

Description
The protein contains two highly conserved, cysteinerich motifs known as LIM domains, which interact with other proteins. As LMO1 has no DNA-binding domain, its DNA binding ability is dependent on the other proteins with which it interacts. The proteins known for binding to LMO1 include TAL1/SCL and LDB1, and the molecules have an oncogenic function in T cell acute leukemia with the chromosomal translocation t(11;14)(p15;q11).
Expression
LMO1 expression is prominent in the central nervous system in both human and mouse. In mice it was observed by an in situ hybridization technique in the cerebral cortex, diencephalon, mesencephalon, cerebellum, myeloencephalon and spinal cord. Northern blot analysis revealed its expression in the thymus, kidney and placenta of adult mice.
Localisation
Nucleus.
Function
Transcription factor.
Mutations
Note Not reported.
Implicated in
Neuroblastoma Disease
Genome-wide association studies revealed a corelation between neuroblastoma and a single nucleotide polymorphism in LMO1 gene, rs110419 (A/G), of which the A allele was shown to promote LMO1 expression and to corelate the cases. The DNA copy number gain of the LMO1 locus due to duplication was also demonstrated to associate with the cases. These findings suggest that the gene has a role in the development and/or progression of neuroblastoma. It was also reported that LMO3 is a neuroblastoma oncogene.
Apoptosis of the gastric epithelial cells
Note
In some gastric-cancer derived cell lines, LMO1 is upregulated by TGFbeta signalling and induces their apoptosis through enhancing GSDMA expression. This TGFbeta-LMO1-GSDMA cascade is considered a mechanism for apoptosis induction in the gastric epithelial cells, and has a role in maintaining their homeostasis.
LMO1 induces apoptosis of the pit cells in TGFbeta signalling.
This function is assumed to have a role in homeostasis of the gastric epithelium.
T-cell acute lymphoblastic leukemia (T-ALL)
Disease Originally, the LMO1 gene was identified at a break point of the translocation t(11;14)(p15;q11), which was frequently observed in T-ALL. Using LMO1 as a probe, LMO2 and LMO3 were identified. LMO1 is expressed in inmature T cells but suppressed in the mature cells, and overexpression of the gene in thymocytes, hematopoeitic progeniter cells located in the thymus, resulted in developing T-ALL in mice. LMO1 acts cooperatively with SCL (Stem cell leukemia) as a transcriptional activator or represser, dependent on the genes and the cells, and enforced expression of LMO1 and SCL in the thymocytes inhibits T-cell differentiation and causes T-ALL. It is known that the LMO1-SCL complex regulates several genes, including suppression of NFKB1 (nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) and PTCRA (pre T-cell antigen receptor alpha), activation of NKX3.1 (NK3 homeobox 1).
